Shawn Tomasello
Tomasello was chief commercial officer of Kite Pharma, where she oversaw the commercialization of the CAR T-cell therapy Yescarta and played a role in the company’s acquisition by Gilead Sciences. She currently serves on the boards of TCR Therapeutics, 4D Molecular Therapeutics, UroGen Pharma, Mesoblast Gamida Cell and Centrexion Therapeutics.
- October 2022
Added to: AlioVir - Waltham, MA
AZlioVir is a late-clinical stage allogeneic T0cell immunotherapy company. Their platforms leverage off-the-shelf, allogeneic, single and multi-virus -specific T cells for patients with T cell deficiencies.